InterShunt has initiated the EASE HF2 early feasibility study of the InterShunt percutaneous atrial shunt catheter (PAS-C) ...

The blood-brain barrier is known to limit the penetration of drug, with ultrasound just one way of circumventing this natural ...

Escala Medical has pulled in €4.5m ($5.3m) to drive market expansion of its Mendit device for women with pelvic organ ...

Philips has announced the expansion of its collaboration with Medtronic, focusing on advancing patient monitoring ...

It is no secret that the UK’s National Health Service (NHS), like many other healthcare systems, is under pressure on ...

A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.

Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...

Spiders can be an uncomfortable presence for many people but thanks to a new development, their silk is set to enhance nerve ...

Nanostics has secured funding from Genome Canada and Genome Alberta to expedite the ClarityDX Prostate test integration into ...

Enterra Medical has commenced the randomised, multi-centre NAVIGATE study, designed to assess Gastric Electrical Stimulation ...

Medical Research Council (MRC) has launched a new £50m ($68.6m) centre spread across collaborator sites in the UK to develop ...

The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.